Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Urology. 2014 Oct 24;84(5):1066–1072. doi: 10.1016/j.urology.2014.06.067

Figure 3.

Figure 3

Adherence rates to a set of nationally endorsed quality measures comparing markets with low to those with high technological capacity for intensity-modulated radiotherapy (“low tech” vs. “high tech”). Adherence rates were calculated based on multivariable multilevel logistic regression models, adjusting for patient and market characteristics. * indicates p<0.05. ADT: androgen deprivation therapy; RadOnc; radiation oncologist.